The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet)

Published:2015-10 Issue:4 Volume:148 Page:1034-1042
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Andrade Joao de,Schwarz Marvin,Collard Harold R.,Gentry-Bumpass Tedryl,Colby Thomas,Lynch David,Kaner Robert J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference10 articles.

1. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management;Raghu;Am J Respir Crit Care Med,2011

2. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?;Flaherty;Am J Respir Crit Care Med,2004

3. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis;Zisman;N Engl J Med,2010

4. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis;Raghu;N Engl J Med,2012

5. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis;Martinez;N Engl J Med,2014

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes;American Journal of Respiratory and Critical Care Medicine;2024-05-01

2. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency;American Journal of Respiratory and Critical Care Medicine;2024-03-15

3. Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseases;BMJ Open Respiratory Research;2024-02

4. An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis;ERJ Open Research;2024-01

5. Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts;Nature Communications;2023-03-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3